Royal Bank of Canada’s Gilead Sciences GILD Stock Holding History

Royal Bank of Canada’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.4M	Sell	218,400 -209,100	-49%	-$29.3M	0.01%	1178
2025 Q4	$52.5M	Buy	427,500 +420,500	+6,007%	+$51.1M	0.01%	922
2025 Q3	$777K	Sell	7,000 -333,000	-98%	-$37.9M	﹤0.01%	4171
2025 Q2	$37.7M	Buy	340,000 +165,000	+94%	+$17.6M	0.01%	1103
2025 Q1	$19.6M	Buy	+175,000	New	+$18.1M	﹤0.01%	1316
2023 Q4	–	Sell	-5,400	Closed	-$405K	–	7289
2023 Q3	$405K	Hold	5,400	–	–	﹤0.01%	4223
2023 Q2	$416K	Hold	5,400	–	–	﹤0.01%	4094
2023 Q1	$448K	Buy	+5,400	New	+$447K	﹤0.01%	3951
2022 Q2	–	Sell	-65,000	Closed	-$3.86M	–	7491
2022 Q1	$3.86M	Hold	65,000	–	–	﹤0.01%	2471
2021 Q4	$4.72M	Hold	65,000	–	–	﹤0.01%	2417
2021 Q3	$4.54M	Hold	65,000	–	–	﹤0.01%	2375
2021 Q2	$4.48M	Sell	65,000 -50,000	-43%	-$3.34M	﹤0.01%	2394
2021 Q1	$7.43M	Buy	115,000 +90,000	+360%	+$5.8M	﹤0.01%	1960
2020 Q4	$1.46M	Sell	25,000 -32,100	-56%	-$1.94M	﹤0.01%	3196
2020 Q3	$3.61M	Buy	57,100 +32,100	+128%	+$2.23M	﹤0.01%	2223
2020 Q2	$1.92M	Buy	+25,000	New	+$1.92M	﹤0.01%	2650
2020 Q1	–	Sell	-94,200	Closed	-$6.12M	–	6788
2019 Q4	$6.12M	Buy	+94,200	New	+$6.13M	﹤0.01%	2009
2019 Q3	–	Sell	-900	Closed	-$61K	–	6848
2019 Q2	$61K	Sell	900 -4,500	-83%	-$296K	﹤0.01%	5160
2019 Q1	$351K	Sell	5,400 -21,300	-80%	-$1.42M	﹤0.01%	3983
2018 Q4	$1.67M	Buy	+26,700	New	+$1.87M	﹤0.01%	2775
2018 Q2	–	Sell	-400,000	Closed	-$30.2M	–	6612
2018 Q1	$30.2M	Buy	400,000 +360,900	+923%	+$28.7M	0.01%	837
2017 Q4	$2.8M	Sell	39,100 -10,100	-21%	-$767K	﹤0.01%	2489
2017 Q3	$3.99M	Sell	49,200 -50,900	-51%	-$3.89M	﹤0.01%	2153
2017 Q2	$7.09M	Buy	100,100 +56,500	+130%	+$3.76M	﹤0.01%	1733
2017 Q1	$2.96M	Sell	43,600 -254,400	-85%	-$17.9M	﹤0.01%	2260
2016 Q4	$21.3M	Sell	298,000 -1,429,900	-83%	-$106M	0.01%	1025
2016 Q3	$137M	Buy	1,727,900 +1,573,000	+1,015%	+$128M	0.08%	215
2016 Q2	$12.9M	Buy	154,900 +73,600	+91%	+$6.53M	0.01%	1273
2016 Q1	$7.47M	Buy	81,300 +2,600	+3%	+$234K	﹤0.01%	1559
2015 Q4	$7.96M	Sell	78,700 -71,300	-48%	-$7.42M	0.01%	1577
2015 Q3	$14.7M	Buy	150,000 +67,900	+83%	+$7.54M	0.01%	935
2015 Q2	$9.61M	Sell	82,100 -1,167,300	-93%	-$128M	0.01%	1235
2015 Q1	$123M	Buy	1,249,400 +1,184,900	+1,837%	+$120M	0.09%	171
2014 Q4	$6.08M	Buy	64,500 +18,000	+39%	+$1.86M	﹤0.01%	1539
2014 Q3	$4.95M	Hold	46,500	–	–	﹤0.01%	1660
2014 Q2	$3.85M	Buy	46,500 +18,500	+66%	+$1.44M	﹤0.01%	1833
2014 Q1	$1.98M	Sell	28,000 -399,500	-93%	-$31.3M	﹤0.01%	2253
2013 Q4	$32.1M	Buy	427,500 +36,100	+9%	+$2.51M	0.02%	542
2013 Q3	$24.6M	Sell	391,400 -8,600	-2%	-$514K	0.02%	618
2013 Q2	$20.5M	Buy	+400,000	New	+$20.8M	0.02%	655

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Royal Bank of Canada's GILD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Gilead Sciences (GILD) stake by 4.5% in Q1 2026, selling an estimated $37.2M and leaving 5,647,122 shares worth $787M. The position accounts for 0.14% of the portfolio, ranked #142.

Royal Bank of Canada first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $973M in Q4 2022. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Royal Bank of Canada held 5,647,122 shares of Gilead Sciences worth $787M as of Q1 2026.
Royal Bank of Canada sold 265,759 Gilead Sciences shares in Q1 2026, an estimated $37.2M.
Gilead Sciences made up 0.14% of Royal Bank of Canada's portfolio in Q1 2026, its #142 holding.
Royal Bank of Canada first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Gilead Sciences position peaked at $973M in Q4 2022.
2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.